reference/11429519

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11429519

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	1120
issn	1651-226X 0284-186X
issueIdentifier	9-10
pageRange	1115-1120
publicationName	Acta oncologica (Stockholm, Sweden)
startingPage	1115
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_111f1b6e0633f44904ff6b8dcef97de6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8075d9d563cbe75004e7b6c2c4360b29
bibliographicCitation	Hillmen P, Janssens A, Babu KG, Kloczko J, Grosicki S, Manson S, McKeown A, Gupta I, Chang CN, Offner F. Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL. Acta Oncol. 2016 Sep;55(9-10):1115–20. doi: 10.1080/0284186x.2016.1205217. PMID: 27494089.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98704006b3a5cd257635e1968751593c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6079300414e0f95c13520776a85e39d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5baeaced258fcb8f229fd4eeae0dcb2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2117c54aa0acc1d96968bdd5c77a66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff430c1c8ca693ffb5461644ae01d90d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e04354828b16f69d06519da7889bb5b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2644-1050 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08cc0553b5d9fa75402a7b2ea1c287d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23ccceaeade1f12641649433afbcbaea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c911a23b3ba5ac9160ddaaf6332737c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_377a73086d765d65f0623d6caef64953
date	2016-08-05^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1080/0284186x.2016.1205217 https://pubmed.ncbi.nlm.nih.gov/27494089
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1637 https://portal.issn.org/resource/ISSN/0284-186X https://portal.issn.org/resource/ISSN/1651-226X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL
discusses	http://id.nlm.nih.gov/mesh/M0519657 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0004118 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D002699Q000627 http://id.nlm.nih.gov/mesh/D000071066 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005221Q000139 http://id.nlm.nih.gov/mesh/D057566 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D015451Q000401
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2708 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720

Showing number of triples: 1 to 62 of 62.